Ivera Medical Corporation, a leading medical device innovator, announced that it has been selected by HealthTrust as a provider of disinfecting caps for I.V. needleless connectors.
The agreement, effective February 2, 2013, will give HealthTrust member facilities—1,400 not-for-profit and for-profit acute care facilities, as well as 10,600 ambulatory and alternate care sites—access to efficacious passive disinfection technology designed to act against the organisms associated with catheter-related bloodstream infections.
The Curos® Port Protector from Ivera is a passive disinfection cap which disinfects and then guards luer activated swabbable valves against contamination between venous accesses. Inside the cap, a 70% IPA (isopropyl alcohol) saturated sponge continually bathes the port to effectively disinfect the device. The effectiveness of Curos port protectors were tested in vitro against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Pseudomonas aeruginosa, Candida glabrata, Candida albicans.* Effective use requires only that caregivers peel off a foil seal and twist the cap onto any needleless connector. The vibrant green cap assures high visibility compliance with hospital infection control protocols while its design minimizes potential alcohol spillage and packaging waste.
“Ivera is very pleased to have been chosen for this contract award. HealthTrust and Ivera share patient safety values by providing innovative solutions designed to address a common source of patient bloodstream infections and contaminated blood cultures and in doing so reducing overall healthcare costs,” said Bob Rogers, chief executive officer of Ivera.
*For more information refer to Wenzel RP and Edmond MB. The Impact of Hospital-Acquired Bloodstream Infections. Emerg Infect Dis. 2001 Mar-Apr;7(2):174-7.